Low IL-1 beta production in leukemic cells from progressive B cell chronic leukemia (B-CLL).

[1]  E. Kimby,et al.  Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS). , 1989, Leukemia research.

[2]  A. George,et al.  Idiotypic vaccination as a treatment for a B cell lymphoma. , 1988, Journal of immunology.

[3]  S. Umland,et al.  'B-cell factors' are pleiotropic. , 1988, Immunology today.

[4]  A. Lanzavecchia.  Exploiting the immune system's own strategies for immunotherapy. , 1988, Immunology today.

[5]  A. Rosén,et al.  Spontaneous production of interleukin 1 activity by chronic lymphocytic leukemic cells. , 1987, Blood.

[6]  C. Grossi,et al.  Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1. , 1987, Blood.

[7]  S. Venuta,et al.  Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line. , 1987, Journal of immunology.

[8]  E. Kimby,et al.  T lymphocyte subpopulations in chronic lymphocytic leukemia of B cell type in relation to immunoglobulin isotype(s) on the leukemic clone and to clinical features , 1987, European journal of haematology.

[9]  A. George,et al.  Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. , 1987, Journal of immunology.

[10]  G. Guy,et al.  The molecules controlling B lymphocytes. , 1987, Immunology today.

[11]  P. Ferrara,et al.  Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell line. , 1986, Journal of immunology.

[12]  M. Ferrarini,et al.  In vitro production of interleukin 1 by normal and malignant human B lymphocytes. , 1986, Journal of immunology.

[13]  R. Bettini,et al.  [Clinical staging of chronic lymphatic leukemia]. , 1986, Recenti progressi in medicina.

[14]  Who Collaborating.  Activation,Proliferation and Differentiation of Human B Lymphocytes , 1985 .

[15]  B. Clarkson,et al.  Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon. , 1980, Journal of immunology.

[16]  N. Kay,et al.  T-cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribtuion and in in vitro receptor maturation. , 1979, Blood.

[17]  H. Kunkel,et al.  T cell helper defect in patients with chronic lymphocytic leukemia. , 1979, Journal of immunology.

[18]  G. Holm,et al.  Lymphocyte subpopulations in chronic lymphocytic leukemia (CLL). Relation to the activity of the disease. , 2009, Acta medica Scandinavica.

[19]  R. Silver,et al.  Guidelines for protocol studies in chronic lymphocytic leukemia , 1978, American journal of hematology.

[20]  E. Cronkite,et al.  Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.

[21]  H. Eisen,et al.  Myeloma proteins as tumor-specific transplantation antigens. , 1972, Proceedings of the National Academy of Sciences of the United States of America.